The long-term clinical outcome of 1-year treatment of chronic hepatitis B with lamivudine-5 years observation
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-09-01
著者
-
Ogata Norio
Department Of Clinical And Laboratory Medicine Toyama Medical And Pharmaceutical University
-
ICHIDA Takafumi
Third Department of Internal Medicine, Faculty of Medicine, Niigata University
-
OHKOSHI Shogo
Third Department of Internal Medicine, Niigata University School of Medicine
-
Ichida Takafumi
Third Department Of Internal Medicine Faculty Of Medicine Niigata University
-
Ohkoshi S
Division Of Gastroenterology And Hepatology Niigata University Graduate School Of Medical And Dental
-
Ichida T
Division Of Gastroenterology And Hepatology Juntendo University School Of Medicine Shizuoka Hospital
-
Ichida Takafumi
Department Of Internal Medicine Iii Niigata University School Of Medicine
関連論文
- Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas
- The long-term clinical outcome of 1-year treatment of chronic hepatitis B with lamivudine-5 years observation
- A Study of Patient with Chronic Non-B, Non-C Hepatitis who Developed Liver Cirrhosis and Hepatocellular Carcinoma Over 14 Years Observation
- Development of Peptide Nucleic Acid Mediated Polymerase Chain Reaction Clamping (PMPC)-Direct Sequencing Method for Detecting Lamivudine-Resistant Hepatitis B Virus (HBV) Variants with High Sensitivity and Specificity
- Comparison of the effects of in-vivo thermal ablation of pig liver by microwave and radiofrequency coagulation
- Sustained response to interferon-α plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells
- Thymosin-α1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B
- Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression
- Treatment of symptomatic primary biliary cirrhosis with lymphocytapheresis: a preliminary clinical trial
- Antibody to Hepatitis B Surface Antigen (AntiHBs) Induced by a Recombinant Hepatitis B Vaccine Consisting of Subtype adr Antigen is Underestimated on the World Health Organization (WHO)-standardized Assay
- Recurrence of hepatocellular carcinoma 102 months after successful eradication and removal of membranous obstruction of the inferior vena cava
- Late Phase Images in Whole Liver Double Phase CT during Hepatic Arteriography in the Diagnosis of Well-differentiated Hepatocellular Carcinomas
- Natural killer cell receptors and their ligands in liver diseases
- Clinicopathological analysis of CD133^+ and NCAM^+ human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas
- A Pregnant Case of Severe Acute Hepatitis Type C Successfully Treatedwith Natural Interferon-Alpha and Showing No Evidence of a MaternalTransmission of HCV to the Newborn
- Antibody to Hepatitis B Surface Antigen (AntiHBs) Induced by a Recombinant Hepatitis B Vaccine Consisting of Subtype adr Antigen is Underestimated on the World Health Organization (WHO)-standardized Assay
- Prophylaxis and post transplant treatment of viral hepatitis after living donor liver transplantation
- Hepatocyte Growth Factor Suppresses the Onset of Liver Cirrhosis and Abrogates Lethal Hepatic Dysfunction in Rats^1